Evidence map›Paper›PMID 22418732›Full record

ArticlePsychopharmacology2012

Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats.

Nicholas E Goeders, Ami Cohen, Barbara S Fox, Marc R Azar, Olivier George, George F Koob

Abstract readComparative Study
In one paragraph

Article in Psychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nicholas E GoedersDepartment of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA. ngoede@lsuhsc.edu
Ami Cohen
Barbara S Fox
Marc R Azar
Olivier George
George F Koob
Scripps Research Institute · USBehavioral Pharma (United States) · USLouisiana State University Health Sciences Center Shreveport · US

Funding

Central mechanisms of nicotine reinforcement and dependenceR01DA023597 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KOOB, GEORGE F. · 2008 to 2012
$1.9M
NIDA NIH HHS DA023597NIDA NIH HHS R01 DA023597
6 · The paper itself

Abstract

rationaleDespite increased education regarding its dangers, cigarette smoking remains a significant public health concern due to serious associated health consequences such as cancer and respiratory and cardiovascular diseases. Most smokers fail in their attempts to quit smoking, and current pharmacological interventions have relatively low levels of efficacy and are associated with significant adverse events. We have previously reported that combinations of metyrapone and oxazepam, administered at doses that were ineffective when delivered singly, resulted in dose-related decreases in cocaine self-administration in rats while not affecting food-maintained responding during the same sessions.

objectivesThe current study was designed to test the effects of the administration of a metyrapone:oxazepam combination on nicotine self-administration in rats.

methodsSeveral dose combinations of metyrapone (12.5, 25 or 50 mg/kg) and oxazepam (5 or 10 mg/kg) were tested in rats trained to intravenously (IV) self-administer nicotine (0.03 mg/kg/infusion) during 1-h self-administration sessions using both fixed-ratio and progressive-ratio (PR) schedules of reinforcement.

resultsThe administration of low doses of metyrapone and oxazepam in combination significantly decreased IV nicotine self-administration in rats. At the lowest doses of 12.5 mg/kg of metyrapone and 5 mg/kg of oxazepam, the drugs alone did not decrease IV nicotine self-administration, but the combination was effective. Varenicline was also tested using the fixed-ratio schedule, and reductions in nicotine intake were similar to those seen with the moderate dose of the combination.

conclusionsThe results of this study suggest a potential utility of the combination of metyrapone and oxazepam for smoking cessation in humans.

Indexed as

AnimalsBenzazepinesDose-Response Relationship, DrugDrug Therapy, CombinationEnzyme InhibitorsHypnotics and SedativesInfusions, IntravenousMaleMetyraponeNicotineOxazepamQuinoxalinesRatsRats, WistarReinforcement ScheduleSelf AdministrationBenzazepinesEnzyme InhibitorsHypnotics and SedativesMetyraponeNicotineOxazepamQuinoxalinesVarenicline

Identifiers

PMID22418732
PMCPMC3464482
OpenAlexW2033956885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.